Dyslipidemia Recent Guidelines

Major Update in Cholesterol Management!
https://drive.google.com/file/d/1ewNS1sdgWLqawJALozZTvP_ltFGPYIs7/view?usp=sharing - Link For Notes

New Dyslipidemia Guidelines Explained in 10 Minutes | Prevent ASCVD Calculator | Dr Vishal Gabale

On March 13, new dyslipidemia guidelines were released by multiple major cardiovascular societies, replacing the older frameworks many clinicians have been following since 2013 and 2018.

This update represents a major conceptual shift in cardiovascular risk assessment and lipid management.

In this video, Dr Vishal Gabale simplifies the entire 123-page guideline document in just a few minutes, explaining the most important clinical changes every physician and medical student should know.

If you are a physician, resident, cardiology trainee, or NEET PG / NEET SS aspirant, this video will help you quickly understand the most important changes in lipid management.

Timestamps

0:00 Introduction – New Dyslipidemia Guidelines Released
0:08 Major Conceptual Changes in Risk Assessment and Treatment
0:25 Overview of the 123 Page Guideline Document
0:41 Key Changes in Risk Assessment and Pharmacotherapy
1:06 Lifestyle Focus and Special Populations
1:28 Why the Guidelines Needed Revision
1:46 Limitations of the Older Pooled Cohort Equation
2:02 Problem of Overtreatment with Previous Risk Models
2:28 Introduction to Prevent ASCVD Calculator
2:45 Addition of 30 Year Cardiovascular Risk Prediction
3:10 Better Risk Calibration Compared to Older Tools
3:34 New Risk Categories in Prevent ASCVD
4:10 Lower Thresholds for Starting Treatment
4:32 Updated Risk Stratification
5:04 LDL Targets Reintroduced in the Guidelines
5:29 LDL Targets for High and Very High Risk Patients
5:54 Early Treatment Strategy from Age 30
6:25 Risk Enhancers in Dyslipidemia
6:40 Genetic and Family Risk Factors
7:21 Inflammatory Conditions and Cardiovascular Risk
7:36 Metabolic Conditions Including CKD and Diabetes
7:44 Female Specific Risk Factors
8:09 Ethnic Risk Factors Including South Asians
8:44 Role of Biomarkers in Risk Assessment
9:01 Lipoprotein A and Apolipoprotein B
9:26 High Sensitivity CRP as a Risk Marker
9:41 Expanded Role of Coronary Calcium Score
10:37 Pharmacotherapy Ladder in Dyslipidemia
10:59 Statins as First Line Therapy
11:08 Addition of Ezetimibe
11:16 Bempedoic Acid for Statin Intolerance
11:36 PCSK9 Inhibitors
12:02 Inclisiran and Future Therapies
12:30 Special Population Considerations
13:06 Pediatric Screening and Childhood Obesity
13:14 HDL Myth Clarified
13:31 Summary of the Paradigm Shift
14:36 Final Takeaways from the New Guidelines

Resources

If you want the detailed table of dyslipidemia treatment mentioned in the video, check the link in the description.

Follow Dr Vishal Gabale

Instagram
health.with.vg

For clinical medicine, guideline updates, and NEET PG learning

#Hashtags

#DyslipidemiaGuidelines
#CardiologyUpdate
#CholesterolManagement
#ASCVD
#MedicalEducation
#NEETPG
#InternalMedicine
#CardiovascularPrevention
#HealthWithVG